Aine Miller Theravance Biopharma, Inc. (TBPH) insider trading activity

Aine Miller is SVP, DEV & HEAD OF IRE OFFICE of Theravance Biopharma, Inc.. Currently has a direct ownership of 214,261 shares of TBPH, which is worth approximately $2.03 Million. The most recent transaction as insider was on Feb 28, 2025, when has been sold 75,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 214K

42.31% 3M change

60.45% 12M change

Total Value Held $2.03 Million

Aine Miller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	BUY Grant, award, or other acquisition	-	75,000 Added 25.93%	214,261 Ordinary Shares
Feb 20 2025	SELL Payment of exercise price or tax liability	$109,109 $9.66 p/Share	11,295 Reduced 7.5%	139,261 Ordinary Shares
Nov 20 2024	SELL Payment of exercise price or tax liability	$100,457 $9.97 p/Share	10,076 Reduced 6.27%	150,556 Ordinary Shares
Aug 20 2024	SELL Payment of exercise price or tax liability	$42,752 $8.22 p/Share	5,201 Reduced 3.14%	160,632 Ordinary Shares
May 20 2024	SELL Payment of exercise price or tax liability	$47,329 $9.1 p/Share	5,201 Reduced 3.04%	165,833 Ordinary Shares
Apr 02 2024	BUY Grant, award, or other acquisition	-	37,500 Added 17.98%	171,034 Ordinary Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$105,095 $8.92 p/Share	11,782 Reduced 8.11%	133,534 Ordinary Shares

Aine Miller

SVP, DEV & HEAD OF IRE OFFICE

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account